In May 2018, pharmaceutical manufacturing firm Aspen Pharma opened a new high-containment facility in Port Elizabeth, South Africa.
Unither is an independent pharmaceutical company specialising in the development and contract manufacture of the pharmaceutical formulations that patients and prescribers prefer :
- Sterile unit-dose vials (Blow, Fill and Seal (BFS) technology)
- Effervescent tablets
- Liquid stick-packs
Unither undergoes regular inspections by national and international health authorities. It is compliant with European cGMP guidelines and has achieved ISO:13485 certification. We export to over 15 countries and attach great importance to the quality of our customer service.
STERILE UNIT-DOSE VIALS (BLOW, FILL AND SEAL TECHNOLOGY)
As Europe’s leading manufacturer of sterile single-dose units, Unither has over 60 different moulds (from 0.25ml to 500ml) and can produce up to 1.5 billion units per year.
We can supply effervescent tablets packaged in tubes or in blister packs.
As Europe’s joint leader in the manufacturing of effervescent tablets, Unither is increasing its production capacity to meet rising market needs.
STICK-PACKS (SINGLE-DOSE UNITS)
The stick-pack presentation is an attractive alternative to liquid sachet or to any currently bottled product in this emerging market.
Unither has invested in a high-performance, flexible production tool located on a site with in-depth experience of liquid and paste formulations.
Located in Bordeaux within an innovation and healthcare cluster, Unither Développement possesses acknowledged expertise in the formulation and analytical development, as well as the production and packaging, of low scale batches.
TYPES OF COLLABORATION :
- Strategic outsourcing: our industrial specialisation in niche markets makes us a reliable partner for mid to long-term product subcontracts
- New product development and manufacture: the development of a new form of an existing product can be a good way to boost a client’s product range
- Turnkey licensing solutions: we develop innovative products – our clients have the commercial skills and resources to market them successfully under their own brand
Unither will be attending the CPhI/ICSE fair that will take place from 13-15 October in Madrid, Spain. Those interested in learning more about Unither services can meet us at booth 8E72, or contact us directly to pre-arrange a meeting. Unither is an independent pharmaceutical company sp
Unither has recently modified its equity: ING Parcom has replaced Société Générale Capital Europe (SGCE) as main shareholder. ING Parcom is a private equity company like SGCE. This move will enable Unither to pursue its development through organic growth or acquisiti